“invitae” Archives

in
Entry Author Date Location
Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal 09/21/20 San Francisco
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx 06/22/20 San Francisco
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
An Entrepreneur’s Quest to Make Seattle a Genome Sciences Hub 09/23/19 Seattle
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Stoke Therapeutics Upsizes IPO, Raises $142M for Dravet Drug R&D 06/18/19 Boston
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business 06/17/19 San Francisco
Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More 12/22/17 National
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More 08/04/17 National
Veritas Buys Curoverse to Bring A.I. Analysis of Genes to the Masses 08/03/17 Boston
Invitae Expands Gene Test Menu With Good Start, CombiMatrix Deals 07/31/17 San Francisco
Texas Roundup: CancerGene, UT System, Blair Garrou, GE & Baker Hughes 06/13/17 Texas
Craig Venter Used Own Posh Health Clinic To Diagnose His Cancer 12/08/16 San Francisco
Invitae Scales Up DNA Test Offerings, Scores Mild Market Bump 03/29/16 San Francisco
New Speakers Join Gene-Edit, Microbiome, Big Data “Disruptors” 12/10 12/02/15 San Francisco
Agenda Posted: Xconomy’s Bay Area Life Science Disruptors On Dec. 10 11/19/15 San Francisco
West Coast Bio Roundup: Theranos, 23andMe, Invitae, Gritstone, Etc. 10/23/15 San Francisco
What’s Your DNA Worth? The Scramble To Cash In On the Genome 10/20/15 National
Xconomy Forum: The Bay Area’s Life Science Disruptors 10/08/15 National
West Coast Biotech Roundup: Gilead, Conatus, Exelixis, and More 09/25/15 San Diego
West Coast Biotech Roundup: Global Blood, Invitae, GeneWEAVE, Adynxx 08/13/15 San Francisco
In Tough Diagnostics World, Will Ruling Out Cancer Be Good Business? 08/04/15 National
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More 02/12/15 Seattle
Aiming for One-Stop Diagnostic Tests, Invitae Raises $102M in IPO 02/12/15 San Francisco
Invitae Receives $101,600,000 New Funding Round 02/11/15 San Francisco
West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More 01/15/15 San Francisco
West Coast Biotech Roundup: Illumina, Atara, Invitae, Canaan & More 10/17/14 San Francisco
Page 1 of 2 next page »